Jco Precision Oncology
Overview
Jco Precision Oncology is a scientific journal, published since 2017 in English. The journal's country of origin is United States and its primary focus area is oncology.
Details
Details
Abbr.
JCO Precis Oncol
Start
2017
End
Continuing
e-ISSN
2473-4284
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 7562
48
SJR / Ranks: 976
2249
CiteScore / Ranks: 2159
8.20
JIF / Ranks: 1820
4.6
Recent Articles
31.
Trendowski M, Lusk C, Wenzlaff A, Neslund-Dudas C, Purrington K, Beebe-Dimmer J, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400558.
PMID: 39854657
Purpose: Although lung cancer is one of the most common malignancies, the underlying genetics regarding susceptibility remain poorly understood. We characterized the spectrum of pathogenic/likely pathogenic (P/LP) germline variants within...
32.
Noguchi T, Ariga S, Moku R, Kikuchi J, Amano T, Maeda T, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400437.
PMID: 39823560
Purpose: Precision medicine plays an important role in the treatment of patients with advanced melanoma. Despite its high incidence in White patients, advanced melanoma is rare in Asian countries, hampering...
33.
Imai M, Nakamura Y, Shin S, Okamoto W, Kato T, Esaki T, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400385.
PMID: 39823559
Purpose: Human epidermal growth factor receptor 2 (HER2)-targeted therapies have shown promise in treating -amplified metastatic colorectal cancer (mCRC). Identifying optimal biomarkers for treatment decisions remains challenging. This study explores...
34.
Zhang G, Zhang S, Zhang H, Wu R, Zheng H
JCO Precis Oncol
. 2025 Jan;
9():e2400875.
PMID: 39787464
No abstract available.
35.
36.
Cicala C, Matito J, Quindos M, Gomez-Peregrina D, Romero-Lozano P, Fernandez-Suarez P, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400497.
PMID: 39787462
Purpose: Less than 5% of GI stromal tumors (GISTs) are driven by the loss of the succinate dehydrogenase (SDH) complex, resulting in a pervasive DNA hypermethylation pattern that leads to...
37.
Li Y, Weng Y, Huang Z, Wu L, Xu S, Xie Y, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400603.
PMID: 39772833
Purpose: Chronoradiobiology has emerged as a potential field of study with therapeutic implications for cancer treatment. We aimed to investigate the association between radiation chronotherapy and the efficacy and toxicity...
38.
Hu Z, Pavlick D, Ross J, Lee S, Eluri M, Javle M
JCO Precis Oncol
. 2025 Jan;
9:e2400712.
PMID: 39772832
Purpose: Biliary tract cancers (BTCs) include intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder cancers. BTCs have a number of genomic alterations, including isocitrate dehydrogenase 1 () mutations, fibroblast growth...
39.
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
Eslinger C, Seddighzadeh B, Yee C, Elsabbagh Z, Pai R, Hartley C, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400450.
PMID: 39772831
Purpose: Pancreatic acinar cell carcinoma (PACC) is a rare and aggressive form of pancreatic cancer that originates in the acinar cells of the exocrine pancreas. In this study, we aimed...
40.
Biller L, Mittendorf K, Horiguchi M, Caruso A, Chittenden A, Ukaegbu C, et al.
JCO Precis Oncol
. 2025 Jan;
9:e2400691.
PMID: 39772830
Purpose: Clinical risk assessment models can identify patients with hereditary cancer susceptibility, but it is unknown how multigene cancer syndrome prediction models compare with syndrome-specific models in assessing risk for...